Karyopharm Therapeutics Falls To US$0.88, But Insiders Sold At Lower Price
Karyopharm Therapeutics Inc.’s (NASDAQ:KPTI) stock price has dropped 11% in the previous week, but insiders who sold US$351k in stock over the past year have had less luck. Insiders would probably have been better off holding on to their shares given that the average selling price of US$1.14 is still lower than the current share price.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for Karyopharm Therapeutics
Karyopharm Therapeutics Insider Transactions Over The Last Year
They previously made a sale of -US$117k worth of shares at a price of…
